{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:55:03Z","timestamp":1780412103550,"version":"3.54.1"},"reference-count":62,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s522756","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:00:11Z","timestamp":1756364411000},"page":"585-600","source":"Crossref","is-referenced-by-count":1,"title":["Real-World Disability Outcomes Among Patients Treated with Cariprazine vs Other Atypical Antipsychotics as Adjunctive Treatment for Major Depressive Disorder"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Prakash","family":"Masand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousam","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Ta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9890-7827","authenticated-orcid":true,"given":"Filmon","family":"Haile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susannah","family":"Ripley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Zanardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lalibert\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0632-6311","authenticated-orcid":true,"given":"Nadia","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,8]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates. Geneva, Switzerland; 2017."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1007\/s12325-024-02817-w","volume":"41","author":"Culpepper","year":"2024","journal-title":"Adv Ther"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40273-021-01019-4","volume":"39","author":"Greenberg","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"4460","DOI":"10.1007\/s12325-023-02622-x","volume":"40","author":"Greenberg","year":"2023","journal-title":"Adv Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1176\/ps.2009.60.8.1024","volume":"60","author":"Bush","year":"2009","journal-title":"Psychiatr Serv"},{"key":"ref6","first-page":"1","author":"Brody","year":"2018","journal-title":"NCHS Data Brief"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cpr.2011.07.004","volume":"31","author":"Richards","year":"2011","journal-title":"Clin Psychol Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1176\/appi.focus.20200008","volume":"18","author":"Severe","year":"2020","journal-title":"Focus"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/mp.2012.33","volume":"18","author":"Moylan","year":"2013","journal-title":"Mol Psychiatry"},{"key":"ref10","volume-title":"Practice Guideline for the Treatment of Patients with Major Depressive Disorder","year":"2010"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0706743716659417","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can J Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1007\/s40263-012-0031-0","volume":"27","author":"Patkar","year":"2013","journal-title":"CNS Drugs"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1176\/appi.ajp.2009.09030312","volume":"166","author":"Nelson","year":"2009","journal-title":"Am J Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.4088\/JCP.v68n0602","volume":"68","author":"Papakostas","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4088\/JCP.8133su1c.01","volume":"70","author":"Thase","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/10401230591002129","volume":"17","author":"Papakostas","year":"2005","journal-title":"Ann Clin Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1517\/14656561003614781","volume":"11","author":"Philip","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1080\/13696998.2018.1484373","volume":"21","author":"Seetasith","year":"2018","journal-title":"J Med Econ"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"896","DOI":"10.18553\/jmcp.2023.29.8.896","volume":"29","author":"Jain","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40263-020-00718-4","volume":"34","author":"Keks","year":"2020","journal-title":"CNS Drugs"},{"key":"ref22","unstructured":"Otsuka Pharmaceutical Co. Abilify (Aripiprazole). full prescribing information. otsuka pharmaceutical co.; 2024."},{"key":"ref23","unstructured":"Otsuka Pharmaceutical Co. Rexulti (brexpiprazole). full prescribing information. otsuka pharmaceutical co.2024."},{"key":"ref24","unstructured":"AbbVie, Inc. VRAYLAR\u00ae. (Cariprazine).full Prescribing Information. AbbVie, Inc.; 2024."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1007\/s00213-016-4382-y","volume":"233","author":"Girgis","year":"2016","journal-title":"Psychopharmacol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1176\/appi.ajp.20220504","volume":"180","author":"Sachs","year":"2022","journal-title":"Am J Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/03007995.2018.1430220","volume":"34","author":"Hobart","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"843","DOI":"10.4088\/JCP.v68n0604","volume":"68","author":"Berman","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/YIC.0b013e3283277614","volume":"24","author":"Trivedi","year":"2009","journal-title":"Int Clin Psychopharmacol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jad.2015.03.004","volume":"178","author":"Hendriks","year":"2015","journal-title":"J Affect Disord"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.18m12202","volume":"80","author":"Kennedy","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/ijnp\/pyw087","volume":"20","author":"Fava","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref33","unstructured":"Nabulsi N, Parikh M, Ta J, et al. The impact of cariprazine on short- and long-term disability among commercially insured patients. Presented at: American Society of Clinical Psychopharmacology Annual Meeting. 2024."},{"key":"ref34","unstructured":"Merative MMRD. 2022. Available from: https:\/\/www.merative.com\/documents\/merative-marketscan-research-databases. Accessed January 08, 2025."},{"key":"ref35","unstructured":"May 2022 National Occupational Employment and Wage Estimates. US Bureau of Labor Statistics. 2022. Available from: https:\/\/www.bls.gov\/oes\/2022\/may\/oes_nat.htm#00-0000. Accessed January 08, 2025."},{"key":"ref36","unstructured":"Monaco K. Disability insurance plans: trends in employee access and employer costs. Beyond the numbers: pay and benefits. U.S. Bureau of Labor Statistics. 2015."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/0022146520921371","volume":"61","author":"Namkung","year":"2020","journal-title":"J Health Soc Behav"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1377\/hlthaff.28.3.761","volume":"28","author":"Drake","year":"2009","journal-title":"Health Aff"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"10172","DOI":"10.3390\/ijerph181910172","volume":"18","author":"Fukuura","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/bsl.2283","volume":"35","author":"Linden","year":"2017","journal-title":"Behav Sci Law"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jad.2021.09.030","volume":"296","author":"Peng","year":"2022","journal-title":"J Affect Disord"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1600-0447.2011.01785.x","volume":"125","author":"Holma","year":"2012","journal-title":"Acta Psychiatr Scand"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/YIC.0b013e328341bb5f","volume":"26","author":"Sheehan","year":"2011","journal-title":"Int Clin Psychopharmacol"},{"key":"ref44","volume-title":"Presented At: Psych Congress","year":"2023"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1080\/03007995.2021.1932446","volume":"37","author":"Vieta","year":"2021","journal-title":"Curr Med Res Opin"},{"key":"ref46","unstructured":"Parikh M, Matthews-Hayes T, Adams JL, Kandukuri L, Yee T, Nabulsi N. Impact of adjunctive cariprazine on mental health\u2013related quality of life in patients with major depressive disorder: a pooled post hoc analysis of clinical trial data. Presented at: American Society of Clinical Psychopharmacology (ASCP) Annual Meeting; Miami Beach, FL."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jad.2024.04.086","volume":"356","author":"Wong","year":"2024","journal-title":"J Affect Disord"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"McIntyre RS, Maletic V, Masand P, et al. Effect of adjunctive cariprazine on symptoms of anhedonia in patients with major depressive disorder. Presented at: American Society of Clinical Psychopharmacology Annual Meeting, 2023; Scottsdale, AZ.","DOI":"10.1017\/S1092852924001597"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"24m15506","DOI":"10.4088\/JCP.24m15506","volume":"86","author":"Fava","year":"2025","journal-title":"J Clin Psychiatry"},{"key":"ref50","unstructured":"Otsuka Pharmaceutical Co. L. REXULTI (brexpiprazole). Full Prescribing Information. 2024."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/ejn.13390","volume":"45","author":"Sokoloff","year":"2017","journal-title":"Eur J Neurosci"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/ijnp\/pyx038","volume":"20","author":"Duric","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00213-012-2896-5","volume":"226","author":"Zimnisky","year":"2013","journal-title":"Psychopharmacology"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/FBP.0000000000000070","volume":"25","author":"Papp","year":"2014","journal-title":"Behav Pharmacol"},{"key":"ref55","unstructured":"Gyertyan I, Saghy K, Kassai F, Kiss B, Szombathelyi Z. Anxiolytic-like activity in rat models of cariprazine (RGH-188), a dopamine d3 receptor preferring antipsychotic agent with d3\/d2 receptor partial agonist activity. Presented at: the 38th Annual Meeting of the Society for Neuroscience; Washington, DC."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1017\/S109285292200013X","volume":"28","author":"McIntyre","year":"2023","journal-title":"CNS Spectr"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1037\/h0087423","volume":"57","author":"Saville","year":"2003","journal-title":"Can J Exp Psychol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1093\/beheco\/arh107","volume":"15","author":"Nakagawa","year":"2004","journal-title":"Behav Ecol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.47626\/2237-6089-2023-0680","author":"Lassen","year":"2024","journal-title":"Trends Psychiatry Psychother"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1185\/03007995.2010.517716","volume":"26","author":"Ivanova","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12888-020-02731-9","volume":"20","author":"Gaspar","year":"2020","journal-title":"BMC Psychiatry"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2147\/CEOR.S398509","volume":"15","author":"Jerry","year":"2023","journal-title":"Clinicoecon Outcomes Res"}],"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/106268","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/106268","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:00:15Z","timestamp":1756364415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/real-world-disability-outcomes-among-patients-treated-with-cariprazine-peer-reviewed-fulltext-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":62,"URL":"https:\/\/doi.org\/10.2147\/ceor.s522756","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}